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Abstract
Background: We present a case of primary infertility related to extreme cervical stenosis, a
subset of cervical factor infertility which accounts for approximately 5% of all clinical infertility
referrals.
Case presentation: A 37 year-old nulligravida was successfully treated with ovulation induction
via recombinant follicle stimulating hormone (FSH) and direct intraperitoneal insemination (IPI).
Anticipating controlled ovarian hyperstimulation with in vitro fertilization/embryo transfer (IVF),
the patient underwent hysteroscopy and cervical recanalization, but safe intrauterine access was
not possible due to severe proximal cervical stricture. Hysterosalpingogram established bilateral
tubal patency and confirmed an irregular cervical contour. Since the cervical canal could not be
traversed, neither standard intrauterine insemination nor transcervical embryo transfer could be
offered. Prepared spermatozoa were therefore placed intraperitoneally at both tubal fimbria under
real-time transvaginal sonographic guidance using a 17 gage single-lumen IVF needle. Supplementary
progesterone was administered as 200 mg/d lozenge (troche) plus 200 mg/d rectal suppository,
maintained from the day following IPI to the 8th  gestational week. A singleton intrauterine
pregnancy was achieved after the second ovulation induction attempt.
Conclusions: In this report, we outline the relevance of cervical factor infertility to reproductive
medicine practice. Additionally, our andrology evaluation, ovulation induction approach,
spermatozoa preparation, and insemination technique in such cases are described.
Background
Cervical factor infertility accounts for ~5% of all clinical
infertility referrals, and common treatments for cervical
stenosis include gamete or zygote intrafallopian transfer,
and corrective surgical procedures designed to lyse stric-
tures responsible for stenosis. However, intrauterine in-
semination (IUI) is usually suggested early as an
appropriate therapeutic consideration when semen pa-
rameters are normal and the suspicion for tubal pathology
is low. However, should the cervical canal be tortuous or
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occluded, neither IUI nor transcervical embryo transfer
(ET) after in vitro fertilization (IVF) may be technically
feasible. While such anatomical challenges essentially
render the intrauterine compartment inaccessible from
below, for selected patients direct intraperitoneal insemi-
nation (IPI) can be an effective treatment option, as de-
scribed in this report.
Case report
A 37 year-old Caucasian nulligravida and her husband
presented for evaluation of primary infertility of approxi-
mately one year duration. Both were in good general
health and neither were smokers. A normal Pap teat was
obtained eight months before presentation, and there was
no history of any prior cervical cytology abnormality. The
provisional diagnosis of cervical stenosis had been made
based on an abnormal hysterosalpingogram (HSG) per-
formed approximately six months before referral. Al-
though the radiograph was technically difficult because of
the inability to pass the catheter fully through the cervical
canal, the study was able to show a pronounced filling de-
fect near the area of the internal cervical os (Figure 1). Fal-
lopian tubes were patent bilaterally, and free
intraperitoneal spill without peritubal loculation was doc-
umented.
Ovarian reserve was estimated as reported previously [1],
with cycle day #2 serum FSH and E2 measured at 7.0 mIu/
ml and <32 pg/ml, respectively. All other laboratory tests
were within normal limits. Andrology evaluation consist-
ed of a semen analysis, which showed total spermatozoa
concentration of 70.5 M/ml, 60% forward progression
motility, and 17% normal forms morphology (1999
WHO criteria). A previous urology consultation had iden-
Figure 1
Early fill view from hysterosalpingogram obtained from our patient with severe cervical stenosis (arrow). Extensive cervical
stricture prohibited passage of insemination or embryo transfer catheters; safe transcervical instrumentation was also impossi-
ble. Bilateral tubal patency was confirmed in the subsequent images.BMC Pregnancy and Childbirth 2002, 2 http://www.biomedcentral.com/1471-2393/2/9
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tified a varicocele, which was repaired without complica-
tion approximately one month before the couple
presented at our center. Four months post-varicocelecto-
my, repeat semen analysis found total spermatozoa con-
centration to be 46 M/ml, 70% forward progression
motility, and 3% normal forms morphology (Kruger strict
criteria).
The couple elected to undergo ovulation induction fol-
lowed by IUI, with the understanding that should such
therapy fail, IVF with intracytoplasmic sperm injection
(ICSI) would be considered [2]. Prior to either therapy
however, hysteroscopy was recommended to map cervical
anatomy with greater precision. Therefore, about one
month after presentation, assessment of cervical and en-
dometrial contours was attempted under general anesthe-
sia, via 3 mm hysteroscope. However, due to extensive
cervical fibrosis, instrumentation proximal to the internal
cervical os was impossible and hysteroscopy was aban-
doned.
The defect identified at surgery was consistent with the
stricture suggested on HSG, which appeared as a "D"-
shaped protrusion into the cervical canal. When the pa-
tient was informed of the operative findings, she essential-
ly decompensated and expressed suicidal ideation. The
planned outpatient procedure was therefore modified to
include a brief hospital stay to facilitate psychiatry consul-
tation and formal mental status examination. She was dis-
charged home in stable condition 14 h after hysteroscopy
following psychiatric clearance for continued fertility
therapy.
Follow-up consultation two weeks post-hysteroscopy in-
cluded discussion of controlled ovarian hyperstimulation
with gamete intrafallopian transfer [3]. IVF+ICSI, fol-
lowed either by tubal embryo transfer [4] or transmyome-
trial embryo transfer [5] was also contemplated, as was
ovulation induction with direct intraperitoneal insemina-
tion (IPI). After evaluating the risks and benefits of such
therapies, the couple elected the latter option. An initial
ovulation induction treatment with IPI occurred two
months after the aborted hysteroscopy, but the patient did
not conceive. The following month, the patient under-
went a second gonadotropin ovulation induction se-
quence using 150 IU/d recombinant FSH (Gonal-F®,
Serono Laboratories; Norwell, Massachusetts USA) plus
150 IU/d human menopausal gonadotropin (Repronex®,
Ferring Pharmaceuticals; Copenhagen, Denmark), both
administered subcutaneously [6]. After a six day follicular
recruitment phase, there were 3 follicles with mean diam-
eter >16 mm. Terminal serum estradiol was ~1200 pg/ml,
and a 12 mm trilaminar endometrium was noted. Nonre-
combinant hCG (10,000 IU; Novarel®, Ferring) was ad-
ministered subcutaneously when serum estradiol and
transvaginal sonography suggested follicular maturity [7].
The patient returned 24 h after hCG injection, where in-
formed consent was again obtained for direct IPI under
real-time transvaginal sonographic guidance. On the day
of insemination, the partner's semen parameters were 70
M/ml with 60% motile cells (morphology analysis not
performed). The specimen was washed twice with human
tubal fluid, and then layered upon a dual-density (90%/
45%) gradient (PureSperm®, Nidacon International;
Gothenburg, Sweden) and centrifuged at 300 g [8]. Resus-
pended to a volume of 10 ml, the sample was then divid-
ed into two components of 5 ml each. These two
equivalent samples were injected directly into the intra-
peritoneal cavity (5 ml to each tubal fimbria). IPI was ac-
complished by 17 gage single-lumen oocyte retrieval
needle (Cook IVF; Spencer, Indiana USA) passed under
transvaginal sonographic guidance. No intravenous seda-
tion was administered, but each vaginal fornix was pre-
treated with 1% lidocaine without epinephrine
(AstraZenica Pharmaceuticals LP; Wilmington, Delaware
USA) via 25 gage spinal needle. After transvaginal mucos-
al puncture, the proximal vagina was reexamined and
good hemostasis was noted. She tolerated the procedure
well and there were no complications. Luteal support
commenced the day after IPI, following a 400 mg/d trans-
mucosal protocol as described previously [9].
The patient had no menses two weeks post-procedure; she
returned for pregnancy test and a serum hCG of 223 mIU/
ml was registered. Two days later, the value had increased
to 411 mIU/ml. One month after insemination, transvag-
inal sonogram revealed a single intrauterine gestational
sac with mean diameter of 15 mm (5 6/7 weeks gesta-
tion). A 5 mm fetal pole (6 0/7 weeks gestation) was also
seen, with embryonic cardiac activity documented by B-
mode Doppler pulse sonography (rate = 124/min). The
intrapartum course remains uncomplicated through the
20th gestational week.
Discussion
While cervical factor infertility accounts for only about
5% of reproductive endocrinolology consultations [10],
this subset of patients nevertheless represents a clinical
group where satisfactory outcomes are attainable when
therapy is properly targeted. In this report, we describe the
management of severe cervical stenosis in a woman with
bilateral tubal patency and a normal intrauterine cavity.
Although prepared to undergo IVF-ET at our facility, the
couple first wanted to attempt pregnancy by a less compli-
cated and less costly method. Unfortunately, the tight cer-
vical canal suggested by HSG (and corroborated at
hysteroscopy) represented an unexpected technical chal-
lenge frustrating their plans both for IVF and IUI.BMC Pregnancy and Childbirth 2002, 2 http://www.biomedcentral.com/1471-2393/2/9
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Intraperitoneal insemination (IPI) warrants consideration
in such cases of cervical stenosis where tubal patency has
been confirmed, no intrauteriune contour defects exist,
and there is no profound male factor infertility diagnosis
[11–13]. As with the more commonly performed IUI, the
efficacy of IPI is directly related to the overall spermatozoa
concentration, motility, and morphology [14,15]. Be-
cause tubal patency had been demonstrated radiographi-
cally in this case, we discussed laparoscopic gamete (or
zygote) intrafallopian transfer as well as ovulation induc-
tion with IPI. The rationale for laparoscopy-based treat-
ments would have been strengthened if multiple
intraperitoneal inseminations had failed, yet controversy
remains as to how many such unsuccessful inseminations
should be performed prior to embarking on the advanced
reproductive technologies [16].
How best to determine which couples would benefit most
from IPI remains undecided, but our decision was influ-
enced by semen parameters and the patient's willingness
to undergo transvaginal needle punctures. Previous inves-
tigators have compared pregnancy rates after IPI and
standard IUI, and found the outcomes to be roughly
equivalent [16]. However, in this case the inability to at-
tain safe instrumentation through an abnormal cervical
canal sharply limited the options for fertility treatment, so
IUI was not possible.
The relationship between de novo cervical stenosis and in-
trapartum events has received less study than the cervical
injury attributable to ablative procedures and subsequent
obstetric outcome [18]. Yet, whether or not the cervical
stenosis observed in our case will be associated later with
a complicated intrapartum course (perhaps mediated by
impaired cervical dilation) remains to be seen and forms
the basis of ongoing research.
Conclusions
Although the anatomical challenges associated with se-
vere cervical stenosis essentially render the intrauterine
compartment inaccessible from below, for selected pa-
tients IPI represents an effective and relatively inexpensive
treatment option. In the absence of fallopian tubal disease
and profound male factor diagnoses, IPI may merit con-
sideration for couples undergoing fertility treatment when
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